Publication list of Sentaro Kusuhara as of July 8, 2021 (Only written inEnglish)
1.
Yamada H, Imai H, Tetsumoto A, Hayashida M, Otsuka K, Miki A, et al.
Cystotomy with or without fibrinogen clot removal for refractory cystoid macularedema secondary to branch retinal vein occlusion. Sci Rep. 2021;11(1):8460.
2.
Sakai D, Matsumiya W, Kusuhara S, Nakamura M. Factors associated withthe development of ocular candidiasis and ocular prognosis with echinocandin
therapy for candidemia. J Ophthalmic Inflamm Infect. 2021;11(1):17.
3.
Nishisho R, Kusuhara S, Sotani N, Kim KW, Katsuyama-Yoshikawa A,Matsumiya W, et al. Changes in choroidal imaging parameters following adalimumab
therapy for refractory noninfectious uveitis. Graefes Arch Clin Exp Ophthalmol.
2021;259(5):1273-80.
4.
Mimura C, Tachihara M, Kusuhara S, Fukuoka H, Nishimura Y. Complete
response in a patient with lung cancer suffering from three pembrolizumab-induced
immune-related adverse events including retinal vasculitis. Respirol Case Rep.
2021;9(4):e00730.
5.
Miki A, Kusuhara S, Otsuji T, Kawashima Y, Miki K, Imai H, et al.
Photodynamic therapy combined with anti-vascular endothelial growth factor therapy
for pachychoroid neovasculopathy. PLoS One. 2021;16(3):e0248760.
6.
Maki H, Mori S, Imai H, Yamada H, Otsuka K, Miki A, et al. Autologous
Scleral Pocket Technique for Ahmed Glaucoma Valve Implantation with Pars Plana
Tube Insertion for Neovascular Glaucoma. J Clin Med. 2021;10(8).
7.
Kim KW, Kusuhara S, Tachihara M, Mimura C, Matsumiya W, Nakamura M.
A case of panuveitis and retinal vasculitis associated with pembrolizumab therapy formetastatic lung cancer. Am J Ophthalmol Case Rep. 2021;22:101072.
8.
Kim KW, Kusuhara S, Katsuyama-Yoshikawa A, Nobuyoshi S, Kitamura M,
Mori S, et al. Changes in Gene Expression Profiling and Phenotype in Aged
Multidrug Resistance Protein 4-Deficient Mouse Retinas. Antioxidants (Basel).
2021;10(3).
9.
Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, Morikawa S, et al.
Clinical Characteristics and Outcomes in 314 Japanese Patients with Bacterial
Endophthalmitis: A Multicenter Cohort Study from J-CREST. Pathogens. 2021;10(4).
10.
Imai H, Tetsumoto A, Yamada H, Hayashida M, Otsuka K, Miki A, et al. LongTerm Effect of Cystotomy with or without the Fibrinogen Clot Removal for Refractory
Cystoid Macular Edema Secondary to Diabetic Retinopathy. Retina. 2021;41(4):84451.
11.
Chubachi A, Miki A, Hayashida M, Sakamoto M, Imai H, Kusuhara S, et al.
Clinical Factors Associated with Low-Contrast Visual Acuity after Reduced-Fluence
Photodynamic Therapy in Patients with Resolved Central Serous Chorioretinopathy
and Good Baseline Visual Acuity. Pharmaceuticals (Basel). 2021;14(4).
12.
Shimura M, Kitano S, Muramatsu D, Fukushima H, Takamura Y, Matsumoto
M, et al. Real-world management of treatment-naive diabetic macular oedema: 2-year
visual outcome focusing on the starting year of intervention from STREAT-DMO
study. Br J Ophthalmol. 2020;104(12):1755-61.
13.
Shimura M, Kitano S, Muramatsu D, Fukushima H, Takamura Y, Matsumoto
M, et al. Real-world management of treatment-naive diabetic macular oedema inJapan: two-year visual outcomes with and without anti-VEGF therapy in theSTREAT-DME study. Br J Ophthalmol. 2020;104(9):1209-15.
14.
Sakai D, Matsumiya W, Kusuhara S, Nakamura M. The choroidal structurechanges in a case with hypertensive choroidopathy. Am J Ophthalmol Case Rep.
2020;18:100710.
15.
Morioka M, Takamura Y, Nagai K, Yoshida S, Mori J, Takeuchi M, et al.
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with

or without topical antibiotics. Sci Rep. 2020;10(1):22122.
16.
Mori S, Kurimoto T, Miki A, Maeda H, Kusuhara S, Nakamura M. Aqp9 GeneDeletion Enhances Retinal Ganglion Cell (RGC) Death and Dysfunction Induced by
Optic Nerve Crush: Evidence that Aquaporin 9 Acts as an Astrocyte-to-Neuron
Lactate Shuttle in Concert with Monocarboxylate Transporters To Support RGC
Function and Survival. Mol Neurobiol. 2020;57(11):4530-48.
17.
Kusuhara S, Nakamura M. Ripasudil Hydrochloride Hydrate in the Treatmentof Glaucoma: Safety, Efficacy, and Patient Selection. Clin Ophthalmol. 2020;14:122936.
18.
Katsuyama A, Kusuhara S, Asahara SI, Nakai SI, Mori S, Matsumiya W, et al.
En face slab optical coherence tomography imaging successfully monitors progressive
degenerative changes in the innermost layer of the diabetic retina. BMJ OpenDiabetes Res Care. 2020;8(1).
19.
Imai H, Tetsumoto A, Inoue S, Takano F, Yamada H, Hayashida M, et al.
Intraoperative Three-Dimensional Fluorescein Angiography-Guided Pars Plana
Vitrectomy for the Treatment of Proliferative Diabetic Retinopathy: The MaximizedUtility of the Digital Assisted Vitrectomy. Retina. 2020.
20.
Hayashida M, Miki A, Nakai S, Matsumiya W, Imai H, Kusuhara S, et al.
Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy inpatients with central serous chorioretinopathy with good baseline visual acuity. PLoS
One. 2020;15(10):e0240557.
21.
Hayashida M, Miki A, Nakai S, Matsumiya W, Imai H, Kusuhara S, et al.
Genetic factors associated with treatment response to reduced-fluence photodynamictherapy for chronic central serous chorioretinopathy. Mol Vis. 2020;26:505-9.
22.
Fukui T, Hosotani S, Soda I, Ozawa T, Kusuhara S, Kakegawa MI, et al.
Current status and progress of concurrent chemoradiotherapy in patients with locallyadvanced non-small cell lung cancer prior to the approval of durvalumab. ThoracCancer. 2020;11(4):1005-14.
23.
Shirasawa M, Fukui T, Kusuhara S, Hiyoshi Y, Nakahara Y, Nishinarita N, etal. Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lungcancer patients with interstitial pneumonia. BMC Cancer. 2019;19(1):163.
24.
Shirasawa M, Fukui T, Kusuhara S, Harada S, Nishinarita N, Hiyoshi Y, et al.
Prognostic differences between oligometastatic and polymetastatic extensive diseasesmall cell lung cancer. PLoS One. 2019;14(4):e0214599.
25.
Sakamoto M, Mori S, Ueda K, Kurimoto T, Kusuhara S, Yamada-Nakanishi Y,
et al. En Face Slab Images Visualize Nerve Fibers With Residual Visual Sensitivity in
Significantly Thinned Macular Areas of Advanced Glaucomatous Eyes. Invest
Ophthalmol Vis Sci. 2019;60(8):2811-21.
26.
Nagano C, Nozu K, Yamamura T, Minamikawa S, Fujimura J, Sakakibara N,
et al. TGFBI-associated corneal dystrophy and nephropathy: a novel syndrome? CEN
Case Rep. 2019;8(1):14-7.
27.
Kimura M, Kusuhara S, Tagami M, Nakamura M. Impaired Retinal
Circulation during Axitinib Treatment for Metastatic Renal Cell Carcinoma. Case
Rep Ophthalmol. 2019;10(1):5-10.
28.
Katsuyama A, Kusuhara S, Nishisho R, Matsumiya W, Azumi A, Nakamura M.
Long-term efficacy and safety of infliximab and cyclosporine combination therapy forrefractory uveoretinitis in Behcet's disease. Clin Ophthalmol. 2019;13:521-7.
29.
Katsuyama A, Kusuhara S, Awano H, Nagase H, Matsumiya W, Nakamura M.
A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl. BMCOphthalmol. 2019;19(1):179.
30.
Kusuhara S, Katsuyama A, Matsumiya W, Nakamura M. Efficacy and safetyof ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma. Graefes
Arch Clin Exp Ophthalmol. 2018;256(4):809-14.
31.
Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology ofDiabetic Retinopathy: The Old and the New. Diabetes Metab J. 2018;42(5):364-76.
32.
Komaki R, Ueda T, Tsuji Y, Miyawaki T, Kusuhara S, Hara S, et al. [Retinalvasculopathy with cerebral leukoencephalopathy carrying TREX1 mutation diagnosedby the intracranial calcification: a case report]. Rinsho Shinkeigaku. 2018;58(2):111-7.
33.
Ogura S, Kurata K, Hattori Y, Takase H, Ishiguro-Oonuma T, Hwang Y, et al.
Sustained inflammation after pericyte depletion induces irreversible blood-retina
barrier breakdown. JCI Insight. 2017;2(3):e90905.
34.
Matsumiya W, Honda S, Otsuka K, Miki A, Nagai T, Imai H, et al. One-year
outcome of combination therapy with intravitreal aflibercept and verteporfin
photodynamic therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin ExpOphthalmol. 2017;255(3):541-8.
35.
Honda S, Miki A, Kusuhara S, Imai H, Nakamura M. Choroidal Thickness ofCentral Serous Chorioretinopathy Secondary to Corticosteroid Use. Retina.
2017;37(8):1562-7.
36.
Miyake M, Yamashiro K, Tabara Y, Suda K, Morooka S, Nakanishi H, et al.
Identification of myopia-associated WNT7B polymorphisms provides insights into themechanism underlying the development of myopia. Nat Commun. 2015;6:6689.
37.
Matsumiya W, Honda S, Otsuka K, Miki A, Nagai T, Imai H, et al.
Comparison of the Effectiveness and Prognostic Factors of Intravitreal Ranibizumab
between Typical Neovascular Age-Related Macular Degeneration and Polypoidal
Choroidal Vasculopathy over 24 Months of Follow-Up. Ophthalmologica.
2015;234(1):33-9.
38.
Tagami M, Matsumiya W, Imai H, Kusuhara S, Honda S, Azumi A. Autologous
antibodies to outer retina in acute zonal occult outer retinopathy. Jpn J Ophthalmol.
2014;58(6):462-72.
39.
Kusuhara S, Negi A. Predicting visual outcome following surgery for idiopathic
macular holes. Ophthalmologica. 2014;231(3):125-32.
40.
Kusuhara S, Matsumiya W, Imai H, Honda S, Tsukahara Y, Negi A.
Evaluating dissociated optic nerve fiber layer appearance using en face layer imaging
produced by optical coherence tomography. Ophthalmologica. 2014;232(3):170-8.
41.
Matsumiya W, Kusuhara S, Shimoyama T, Honda S, Tsukahara Y, Negi A.
Predictive value of preoperative optical coherence tomography for visual outcome
following macular hole surgery: effects of imaging alignment. Jpn J Ophthalmol.
2013;57(3):308-15.
42.
Matsumiya W, Honda S, Kusuhara S, Tsukahara Y, Negi A. Effectiveness of
intravitreal ranibizumab in exudative age-related macular degeneration (AMD):comparison between typical neovascular AMD and polypoidal choroidal vasculopathy
over a 1 year follow-up. BMC Ophthalmol. 2013;13:10.
43.
Matsuo M, Honda S, Matsumiya W, Kusuhara S, Tsukahara Y, Negi A.
Comparison between anti-vascular endothelial growth factor therapy andphotodynamic therapy for myopic choroidal neovascularization. Eur J Ophthalmol.
2012;22(2):210-5.
44.
Matsumiya W, Kusuhara S, Yamada Y, Azumi A, Negi A. Sweet's syndrome
with panuveitis resembling Behcet's disease. Jpn J Ophthalmol. 2012;56(3):268-72.
45.
Matsumiya W, Kusuhara S, Hayashibe K, Maruyama K, Kusuhara H, Tagami
M, et al. Forskolin modifies retinal vascular development in Mrp4-knockout mice.
Invest Ophthalmol Vis Sci. 2012;53(13):8029-35.
46.
Kusuhara S, Fukushima Y, Fukuhara S, Jakt LM, Okada M, Shimizu Y, et al.
Arhgef15 promotes retinal angiogenesis by mediating VEGF-induced Cdc42
activation and potentiating RhoJ inactivation in endothelial cells. PLoS One.
2012;7(9):e45858.
47.
Honda S, Bessho H, Kondo N, Kusuhara S, Tsukahara Y, Negi A. Positive
association of CD36 gene variants with the visual outcome of photodynamic therapy
in polypoidal choroidal vasculopathy. Mol Vis. 2012;18:2796-804.
48.
Bessho H, Honda S, Kondo N, Kusuhara S, Tsukahara Y, Negi A. Theassociation of CD36 variants with polypoidal choroidal vasculopathy compared totypical neovascular age-related macular degeneration. Mol Vis. 2012;18:121-7.
49.
Yanagisawa S, Kondo N, Miki A, Matsumiya W, Kusuhara S, Tsukahara Y, etal. A common complement C3 variant is associated with protection against wet agerelated macular degeneration in a Japanese population. PLoS One. 2011;6(12):e28847.
50.
Yanagisawa S, Kondo N, Miki A, Matsumiya W, Kusuhara S, Tsukahara Y, etal. Difference between age-related macular degeneration and polypoidal choroidal
vasculopathy in the hereditary contribution of the A69S variant of the age-related
maculopathy susceptibility 2 gene (ARMS2). Mol Vis. 2011;17:3574-82.
51.
Tagami M, Kusuhara S, Imai H, Honda S, Tsukahara Y, Negi A. Impact of
intravitreal injection of tissue plasminogen activator on full-field electroretinogram inpatients with macular oedema secondary to retinal vein occlusion. Ophthalmologica.
2011;226(2):81-6.
52.
Matsumiya W, Honda S, Bessho H, Kusuhara S, Tsukahara Y, Negi A. Early
responses to intravitreal ranibizumab in typical neovascular age-related maculardegeneration and polypoidal choroidal vasculopathy. J Ophthalmol. 2011;2011:742020.
53.
Kusuhara S, Ooto S, Kimura D, Itoi K, Mukuno H, Miyamoto N, et al.
Intraocular gas dynamics after 20-gauge and 23-gauge vitrectomy with sulfur
hexafluoride gas tamponade. Retina. 2011;31(2):250-6.
54.
Kishimoto H, Kusuhara S, Matsumiya W, Nagai T, Negi A. Retinal surface
imaging provided by Cirrus high-definition optical coherence tomography prominently
visualizes a dissociated optic nerve fiber layer appearance after macular hole surgery.
Int Ophthalmol. 2011;31(5):385-92.
55.
Tagami M, Kusuhara S, Imai H, Uemura A, Honda S, Tsukahara Y, et al.
MRP4 knockdown enhances migration, suppresses apoptosis, and produces
aggregated morphology in human retinal vascular endothelial cells. Biochem Biophys
Res Commun. 2010;400(4):593-8.
56.
Matsumiya W, Honda S, Imai H, Kusuhara S, Tsukahara Y, Negi A. A Case of
Bilateral Macular Holes Showing Onset and Spontaneous Closure over Very ShortIntervals. Case Rep Ophthalmol. 2010;1(2):47-52.
57.
Honda S, Nagai T, Kondo N, Fukuda M, Kusuhara S, Tsukahara Y, et al.
Therapeutic effect of oral bisphosphonates on choroidal neovascularization in thehuman eye. J Ophthalmol. 2010;2010.
58.
Tagami M, Kusuhara S, Honda S, Tsukahara Y, Negi A. Expression of ATPbinding cassette transporters at the inner blood-retinal barrier in a neonatal mousemodel of oxygen-induced retinopathy. Brain Res. 2009;1283:186-93.
59.
Nakamura M, Kanamori A, Nagai-Kusuhara A, Kusuhara S, Yamada Y, NegiA. Serous macular detachment due to diabetic papillopathy detected using opticalcoherence tomography. Arch Ophthalmol. 2009;127(1):105-7.
60.
Tagami M, Kusuhara S, Honda S, Tsukahara Y, Negi A. Rapid regression ofretinal hemorrhage and neovascularization in a case of familial exudative
vitreoretinopathy treated with intravitreal bevacizumab. Graefes Arch Clin Exp
Ophthalmol. 2008;246(12):1787-9.
61.
Ooto S, Kimura D, Itoi K, Mukuno H, Kusuhara S, Miyamoto N, et al.
Suprachoroidal fluid as a complication of 23-gauge vitreous surgery. Br J Ophthalmol.
2008;92(10):1433-4.
62.
Nagai-Kusuhara A, Nakamura M, Kanamori A, Nakanishi Y, Kusuhara S,Negi A. Evaluation of optic nerve head configuration in various types of optic
neuropathy with Heidelberg Retina Tomograph. Eye (Lond). 2008;22(9):1154-60.
63.
Kusuhara S, Ooto S, Kimura D, Itoi K, Mukuno H, Miyamoto N, et al.
Outcomes of 23- and 25-gauge transconjunctival sutureless vitrectomies for idiopathic
macular holes. Br J Ophthalmol. 2008;92(9):1261-4.
64.
Uemura A, Kusuhara S, Wiegand SJ, Yu RT, Nishikawa S. Tlx acts as aproangiogenic switch by regulating extracellular assembly of fibronectin matrices inretinal astrocytes. J Clin Invest. 2006;116(2):369-77.
65.
Uemura A, Kusuhara S, Katsuta H, Nishikawa S. Angiogenesis in the mouse
retina: a model system for experimental manipulation. Exp Cell Res. 2006;312(5):67683.
66.
Kusuhara S, Nakamura M, Nagai-Kusuhara A, Nakanishi Y, Kanamori A,

Negi A. Macular thickness reduction in eyes with unilateral optic atrophy detectedwith optical coherence tomography. Eye (Lond). 2006;20(8):882-7.
67.
Tatsumi Y, Kanamori A, Kusuhara A, Nakanishi Y, Kusuhara S, Nakamura M.
Retinal nerve fiber layer thickness in optic tract syndrome. Jpn J Ophthalmol.
2005;49(4):294-6.
68.
Nakamura M, Kanamori A, Kusuhara S, Ishibashi K, Negi A. Alternate total
ophthalmoplegia and optic neuropathy associated with ulcerative colitis. Eye (Lond).
2005;19(2):235-7.
69.
Nagai A, Nakamura M, Kusuhara S, Kanamori A, Negi A. Unilateralmanifestation of Leber's hereditary optic neuropathy after blunt ocular trauma. Jpn JOphthalmol. 2005;49(1):65-7.
70.
Imai H, Kusuhara S, Nakanishi Y, Teraoka Escano MF, Yamamoto H,Tsukahara Y, et al. A case of POEMS syndrome with cystoid macular edema. Am JOphthalmol. 2005;139(3):563-6.
71.
Kusuhara S, Teraoka Escano MF, Fujii S, Nakanishi Y, Tamura Y, Nagai A, etal. Prediction of postoperative visual outcome based on hole configuration by opticalcoherence tomography in eyes with idiopathic macular holes. Am J Ophthalmol.
2004;138(5):709-16.
72.
Kanamori A, Nakamura M, Matsui N, Nagai A, Nakanishi Y, Kusuhara S, etal. Optical coherence tomography detects characteristic retinal nerve fiber layer
thickness corresponding to band atrophy of the optic discs. Ophthalmology.
2004;111(12):2278-83.
73.
Jiang YL, Escano MF, Sasaki R, Fujii S, Kusuhara S, Matsumoto A, et al.
Ionizing radiation induces a p53-dependent apoptotic mechanism in ARPE-19 cells.
Jpn J Ophthalmol. 2004;48(2):106-14.
74.
Yamamoto H, Yakushijin K, Kusuhara S, Escano MF, Nagai A, Negi A. A
novel RDH5 gene mutation in a patient with fundus albipunctatus presenting withmacular atrophy and fading white dots. Am J Ophthalmol. 2003;136(3):572-4.